Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (1011-1020 of 1,175) with videos related to

Pageof 118
Sort By:
International Journal of Particle Therapy|May 17, 2024
Effects on Lung Tissue After Breast Cancer Radiation: Comparing Photon and Proton TherapiesShruti Siva Kumar, Julie A Bradley, Nancy P Mendenhall, et al.
Medical Physics|March 24, 2021
Automated detection of aggressive and indolent prostate cancer on magnetic resonance imagingArun Seetharaman, Indrani Bhattacharya, Leo C Chen, et al.
International Journal of Molecular Epidemiology and Genetics|April 9, 2013
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE studyJennifer D Brooks, Sharon N Teraoka, Kathleen E Malone, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
The Journal of Clinical Investigation|January 2, 2026
Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenograftsDalin Zhang, Chun-Lung Chiu, Fernando Jose Garcia Marques, et al.
Cancer Medicine|March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancerFrankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 25, 2015
Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculationJefferson C Frisbee, Joshua T Butcher, Stephanie J Frisbee, et al.
Cancer Research|October 31, 2019
Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic OutcomesRobert S Oakes, Grace G Bushnell, Sophia M Orbach, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Pageof 118

Showing results (1011-1020 of 1,175) with videos related to

Sort By:
Pageof 118
International Journal of Particle Therapy|May 17, 2024
Effects on Lung Tissue After Breast Cancer Radiation: Comparing Photon and Proton TherapiesShruti Siva Kumar, Julie A Bradley, Nancy P Mendenhall, et al.
Medical Physics|March 24, 2021
Automated detection of aggressive and indolent prostate cancer on magnetic resonance imagingArun Seetharaman, Indrani Bhattacharya, Leo C Chen, et al.
International Journal of Molecular Epidemiology and Genetics|April 9, 2013
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE studyJennifer D Brooks, Sharon N Teraoka, Kathleen E Malone, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
The Journal of Clinical Investigation|January 2, 2026
Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenograftsDalin Zhang, Chun-Lung Chiu, Fernando Jose Garcia Marques, et al.
Cancer Medicine|March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancerFrankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 25, 2015
Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculationJefferson C Frisbee, Joshua T Butcher, Stephanie J Frisbee, et al.
Cancer Research|October 31, 2019
Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic OutcomesRobert S Oakes, Grace G Bushnell, Sophia M Orbach, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Pageof 118